Professional Documents
Culture Documents
Docket 77100 Document 2019-09545
I. INTRODUCTION
Despite the death of the condemned inmate awaiting execution (Scott Dozier)
at the core of this case, the State’s appeals are not moot. Live issues remain viable here,
because the underlying scenario is capable of repetition yet evading review. Any doubt
regarding the potential for repetition yet evading review was removed on or about
February 21, 2019. On that date, the Office of Attorney General received a service
copy of an in pro per motion from condemned inmate Kevin James Lisle (49948)
wherein he has sought to inform the United States District Court for the District of
Nevada that he desires to waive his pending appeals “with the complete and competent
understanding that ELY STATE PRISON EXECUTIONERS will put him to death
by lethal means.”1
The State has a legal duty to enforce capital punishment statutes under NRS
176.355 by carrying out executions. Given Lisle’s clear intention to waive his appeals
with the understanding that he would be put to death, there is every reason to believe
Lisle’s execution could and would take place prior to January 30, 2020, which is the
expiration date of the last batch of midazolam in possession of the State and that is
subject to the current preliminary injunction. While the State would welcome this
Court’s summarily vacating the preliminary injunction so that it could use the
See
Exh. A at 1 (motion brief from condemned inmate Kevin Lisle #49948
1
1
Alvogen’s midazolam product in this (or any other) anticipated execution, Alvogen has
informed the State that should the preliminary injunction be summarily vacated by this
Court, it would move to enjoin the use of its midazolam product in Lisle’s execution.
Thus, not only is this situation capable of repetition yet evading review, judicial
economy weighs in favor of this Court deciding this case now as opposed later.
injunction appeal is not moot because at a minimum, the interplay between NRS
Chapter 176 and the District Court's authority to issue a preliminary injunction is
capable of repetition yet evading review. Without the Court deciding this legal issue,
summarily vacating the preliminary injunction with the understanding that Alvogen
will again move to block any other executions that may be scheduled prior to the
expiration of Alvogen’s midazolam product, would result in the State’s inability to carry
out executions and fulfill its legal duty to enforce capital punishment statutes, which
II. ARGUMENT
Nev. 599, 602, 245 P.3d 572, 574 (2010). A case becomes moot when "this court is
unable to grant effective relief." Id. "A civil case will not be considered moot if an
aggrieved party diligently and actively seeks relief from discernible and substantial
consequences flowing from a lower tribunal's judgment." Boulet v. City of Las Vegas, 96
2
Nev. 611, 613-14, 614 P.2d 8, 10 (1980). The party asserting mootness has a heavy
burden. Los Angeles CO. v. Davis, 440 U.S. 625, 631 (1979).
injunction, the issues presented in the preliminary injunction remain live for review if
they are subject to repetition. See Dickstein v. Williams, 93 Nev. 605, 608–10, 571 P.2d
A case is not moot as long as any single issue remains viable, as the remaining
issue satisfies the case-or-controversy requirement. See Valley Health Sys., LLC v. Estate
of Doe, 134 Nev. Adv. Op. 76, 427 P.3d 1021, 1026 n.1 (2018); Toxco, Inc. v. Chu, 801 F.
This Court "may still consider [a] case as a matter of widespread importance
capable of repetition, yet evading review" if "(1) the duration of the challenged action
is relatively short, (2) there is a likelihood that a similar issue will arise in the future, and
(3) the matter is important." Birch v. Las Vegas Metro Police Dep't, 129 Nev. 328, 334, 302
This Court has repeatedly recognized the important issues presented in this case
generally and it is no less true for the specific controversy over the State’s ability to
enforce capital punishment statutes and carry out its legal duty to execute condemned
inmates. It is a scenario that is likely to reoccur but avoid review due to subsequent
3
preliminary injunctions. The State must carry out an execution within a 30-day window
of time designated by the sentencing district court. See NRS 176.345(1)(b); see also NRS
176.355(2)(a).
approximately nine months fall within the “capable of repetition, yet evading review”
exception to the mootness doctrine. See McCormack v. Herzog, 788 F.3d 1017, 1026 (9th
Cir. 2015). Here, the time period to carry out an execution is a single month (30 days).
Because of the short duration involved, the issues in this case are capable of repetition
in a future execution, as issued in this case, would disrupt the ability of the State to carry
out the execution within the 30-day window of time as required by Nevada law. By the
time litigation regarding the preliminary injunction resolved, the sentencing district
court’s order would have expired, and the State would face a renewed cycle of litigation.
would seek—related to Lisle’s wish to waive his appeals and be executed or otherwise—
would lead to the expiration (and uselessness) of the last two batches of Alvogen’s
midazolam’s product in the States’ possession, as those batches will expire on June 30,
So long as Nevada law provides for capital punishment, there is a likelihood that
similar issues as presented in this case will arise in the future. The Court should not
4
consider the issues presented here moot, especially in light of pending legislation that
consideration of legislation that may alter capital punishment statutes reveals the public
importance of the issues in this case. Furthermore, the United States Court of Appeals
for the Ninth Circuit recently inquired into the status of this case during oral argument,
demonstrating that other courts consider the issues presented here both important and
likely to occur again.3 Additionally, another condemned inmate has recently expressed
his desire to waive his appellate challenges, which will likely create a similar scenario as
this case.4
Because this case presents issues that fall within a short duration, are likely to
arise in the very near future given Lisle’s expressed wishes, and are of importance to
both the State of Nevada (as it has a legal duty to carry out any pending executions) and
Alvogen (as it attempts to block its product from being used in executions without its
consent), these appeals are not moot, and the Court should consider them in light of
2
See generally A.B. 149, 80th Leg. Session (Nev. 2019).
See, Oral Argument in Zane Floyd v. Timothy Filson, No. 14-99012, UNITED STATES
3
5
III. CONCLUSION
For these reasons, the State's appeals are not moot and should not be dismissed.
Therefore, the State respectfully request that the Court should consider these cases in
due course.
6
CERTIFICATE OF SERVICE
RESPONSE TO ORDER TO SHOW CAUSE with the Clerk of the Court for the
Nevada Supreme Court by using the appellate CM/ECF system on March 1, 2019.
Participants in the case who are registered CM/ECF users will be served by the
7
Exhibit A
Motion Brief